1. Academic Validation
  2. Lancao decoction alleviates Alzheimer's disease: Depending on activating CaMKII to protect neuronal refunction by reducing β-amyloid in the hippocampus

Lancao decoction alleviates Alzheimer's disease: Depending on activating CaMKII to protect neuronal refunction by reducing β-amyloid in the hippocampus

  • J Ethnopharmacol. 2025 Apr 9:345:119619. doi: 10.1016/j.jep.2025.119619.
Lei Wu 1 Yan Sun 2 Lingang Zhao 3 Shan Xing 4 Ruiyi Liu 4 Nga Lee Wong 4 Yuesong Lin 3 Chenghao Song 4 Chao Lu 5 Hailou Zhang 6
Affiliations

Affiliations

  • 1 Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Department of Pharmacy, Nanjing, 210029, China.
  • 2 Key Laboratory of Integrative Biomedicine for Brain Diseases, School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • 3 Nanjing Liuhe District Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, 211599, China.
  • 4 Interdisciplinary Institute for Personalized Medicine in Brain Disorders, Jinan University, School of Chinese Medicine, Guangzhou, 510632, China.
  • 5 Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Department of Pharmacy, Nanjing, 210029, China. Electronic address: sinkly228@126.com.
  • 6 Interdisciplinary Institute for Personalized Medicine in Brain Disorders, Jinan University, School of Chinese Medicine, Guangzhou, 510632, China; f GHM Joint Laboratory of Traditional Chinese Medicine on Brain-Peripheral Homeostasis and Comprehensive Health, Jinan University, School of Chinese Medicine, Guangzhou, 510632, China; Zhuhai Institute of Jinan University, Zhuhai, 519070, China. Electronic address: hailouzhang@163.com.
Abstract

Ethnopharmacological relevancy: Lancao decoction (LC) is a traditional Chinese medicine (TCM) formulation mentioned in the "Huangdineijing", known for its ability to dispel turbidity and eliminate heat. TCM believes that the etiology of Alzheimer's disease (AD) is phlegm turbidity, and the fiery internal obstruction of the gods, which suggests that LC has the possibility of treating.

Aim of the study: This investigation will examine the possibilities of LC to improve AD and uncover the underlying mechanisms.

Materials and methods: Gas chromatography (GC) and HPLC-MS were used to identify the content of the primary elements in LC and test the stability of its extraction. The function of LC in ameliorating AD was characterized by utilizing behavioral assessments such as the Morris water maze (MWM) and the Y-maze in AD modeling mice. Levels of molecular signaling and neurogenesis within the hippocampus was assessed using Western blot and immunostaining. Pharmacological interventions were used to explore the association of specific targets with neurogenesis and synaptic proteins and their contributions in LC improvement of AD.

Results: The main components of LC include p-Cymene, 3-Methoxy-p-cymene, neryl acetate, gallic acid, protocatechuic acid and euparin. APP/PS1 mice displayed behavioral characteristics indicative of memory and learning deficits, such as a notably longer time taken to reach the platform and reduced time spent in the area without the platform in the Morris Water Maze (MWM), as well as a longer delay in exploring the new arm and less time spent in the new arm in the Y-maze, when compared to C57BL6/J mice. However, these impairments were alleviated by chronic treatment with either LC or donepezil (DON) over a period of 14 days. Additionally, the phosphorylated levels of CaMKII and the amounts of synaptic proteins (synapsin1 and PSD95) were greatly diminished within the hippocampal region of APP/PS1 mice, which were also reversed by LC or DON. In addition, Aβ area was obviously increased in the hippocampus of the APP/PS1 murine model, which was also reversed by LC or DON. Inhibition of CaMKII activities not only blunted LC's therapeutic actions of AD, but also blocked the enhancements of LC on synaptic proteins in the hippocampus, the quantity of cells that are co-stained with BrdU and DCX, and Ki67-positive cells located in the dentate gyrus (DG) of the hippocampus.

Conclusion: The results indicated that LC activated CaMKII to relieve Aβ formation, thereby enhancing neuronal functions in the hippocampus, and thus alleviated AD, which provided a theoretical basis for a deeper understanding of the mechanism, clinical application, and subsequent research of LC in alleviating AD.

Keywords

Alzheimer’s disease; CaMKII; Lancao decoction; Neuronal activities; Synaptic protein; β-amyloid.

Figures
Products